Clinical Trial Update: Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating liraglutide in obese adults with moderate to severe obstructive sleep apnea has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2015-02-09